Stuart M. Essig
CEO, President & ChairmanDr. Stuart M. Essig, Ph.D., was Executive-in-Residence at Chp Management, Inc. He is Independent Director of Piper Sandler Companies from February 4, 2026. He served as an Executive Advisor and Senior Advisor at Water Street Healthcare Partners, LLC. He served as Independent Director at Orthofix Medical Inc., since January 4, 2023 until June 19, 2024. He serves as Chairman of the Board of Mission Bio, Inc., since March 2022. He serves as the Founder, Managing Director and Managing Partner at Prettybrook Partners LLC. Dr. Essig co-founded Prettybrook Partners LLC in 2012. He has been a Venture Partner of Wellington Ventures since March 2013 and served as its Chief Executive Officer from December 1997 to January 3, 2012 and as its President from December 1997 to November 2010. He joined Wellington Ventures in December 1997. Dr. Essig helps in developing Wellington’s and Prettybrook Partners’s presence in the United States of America and focuses on life sciences and medical technology investments. He serves as Lead Director at Breg, Inc., since October 2020. Dr. Essig is the Founding Investor Member of Tigerlabs. He serves as Director at Breg, Inc. Dr. Essig is Chairman of Integra LifeSciences Holdings Corporation since January 2012 and serves as its President & CEO since May 01, 2026. Dr. Essig was Executive Chairman of Integra LifeSciences Holdings Corporation from February 27, 2024. Dr. Essig joined the Integra LifeSciences Holdings Corporation in December 1997 as Director. Dr. Essig was Independent Chairman of the Board of Integra LifeSciences Holdings Corporation from January 2012 to February 27, 2024. He previously served as Integra’s chief executive officer from 1997 through early 2012 and as its President from 1997 until 2010. He transitioned the business into a global surgical products company, growing revenues during his tenure as the Chief Executive Officer. Dr. Essig was employed at Theken Spine, LLC. He served as Chief Executive Officer and President of Reconstructive Technologies, Inc. He served as Managing Director of health care and Managing Director of the medical technology practice at Goldman, Sachs & Co., and as Managing Director in mergers and acquisitions at The Goldman Sachs Group, Inc., specializing in the medical device, pharmaceutical and biotechnology sectors. He supervised the medical technology practice at the firm. He had broad healthcare experience at Goldman Sachs, serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients. He served as Executive Chairman of Breg, Inc., since July 23, 2012 until October 2020. He served as a Member of the Senior Advisory Board of TowerBrook Capital Partners, L.P. Dr. Essig has served as Lead Director and participated in CEO succession processes, on the boards of numerous public companies in levered market capitalization. He served as Director of Owens & Minor, Inc since October 30, 2013 until August 2019. He previously served on the Board of Directors of St. Jude Medical Corporation from 1999 to 2017. He serves as a Board Observer of Dynatronics Corporation. Dr. Essig served as a Director at Neuromedical Systems since 1993. From March 2005 until August 2008, he served on the Board of Directors of Zimmer Holdings, Inc. He served as a Director of Vital Signs Inc., from 1998 to 2002 and Zimmer Biomet Holdings, Inc., from March 18, 2005 to August 2008. Dr. Essig has also served as Treasurer at ADVAMED. He serves as a Director of Availity, L.L.C. He has been an Independent Director of SeaSpine Holdings Corporation since June 2015 and has been its Lead Independent Director since July 2015. He has been an Independent Director of IDEXX Laboratories, Inc., since July 12, 2017. He serves on the Leadership Counsel of the Princeton University School of Engineering and Applied Sciences. Dr. Essig has served on the boards of publicly traded companies and has extensive knowledge of the health care industry. Dr. Essig serves on the Board of Directors of Piper Sandler Companies, IDEXX Laboratories, Inc., and on the Board of Managers of Availity, LLC. He holds a Ph.D. degree in Financial Economics from 1988 to 1992 and a Master of Business Administration degree in Financial Economics from 1985 to 1987, both from the University of Chicago, Booth School of Business; and received an A.B. degree and graduated with magna cum laude and Phi Beta Kappa honors from the Woodrow Wilson School of Public and International Affairs at Princeton University from 1979 to 1983.
Positions
- Company NameIntegra LifeSciences Holdings CorporationStock CodeIARTPositionCEO, President & ChairmanColleagues
- LDLea Daniels KnightExecutive VP & CFO
- RTRobert T. DavisExecutive Vice President of Tissue Reconstruction and Distributed Technologies
- MJMichael J. McBreenExecutive VP & Chief Commercial Officer
- HPHarvinder Pal SinghExecutive VP & President of International Business
- CSChristian S. SchadeIndependent Director
- BBBarbara Benton HillIndependent Presiding Director
- RWRenee Wonlai LoIndependent Director
- KNKeith N. G. BradleyIndependent Director
- Company NameDynatronics CorporationStock CodeDYNTQPositionBoard ObserverColleagues
- BDBrian D. BakerCFO, CEO, President, Principal Accounting Officer & Director
- ESErin S. EnrightIndependent Chairman of the Board
- RSRyan StaatsChief Operating Officer
- MWMike WithersChief Information Officer & Human Resources Leader
- DBDavid B. HoltzIndependent Director
- RSR. Scott WardIndependent Director
- SMStuart M. EssigBoard Observer
- Company NameIDEXX Laboratories, Inc.Stock CodeIDXXPositionIndependent DirectorColleagues
- JJJonathan J. MazelskyExecutive Chairman
- AEAndrew EmersonExecutive VP, CFO & Treasurer
- MJMichael J. LaneExecutive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology
- MSMartin SmithExecutive Vice President of Global Operations and R&D
- MGMichael G. EricksonCEO, President & Director
- SMStuart M. EssigIndependent Director
- SASam A. SamadIndependent Director
- ICIrene Chang BrittIndependent Director
